# OnCo record nct06481592 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06481592/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06481592", "NCT06481592" ;
  schema:name "A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer."@en ;
  schema:description "A phase 2 trial of Lifileucel in endometrial cancer, run by Iovance Biotherapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06481592/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06481592> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-10-29" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/> ;
  onco:technologies <https://onco.cc/technologies/til-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lifileucel/> ;
  onco:companies <https://onco.cc/companies/iovance/> .
